Ranbaxy has target of Rs 550:
VVLN Shastri of Firstcall India Equity Advisor is of the view that Ranbaxy Laboratories has target of Rs 550.
Ranbaxy has gained 4.8% to Rs 526, Bhel has advanced 2.2% to Rs 1,374.